Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa
- PMID: 20691272
- DOI: 10.1016/j.jsb.2010.07.012
Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa
Abstract
Pseudomonas aeruginosa is responsible for around 10% of all hospital-acquired infections and the single most important pathogen of cystic fibrosis lungs. P. aeruginosa has high intrinsic and acquired antibiotic resistance, due to the extrusion of antibiotics by multidrug efflux pumps. The gene regulator MexZ controls the expression of mexXY, the efflux pump responsible for resistance to many drugs that are used for treating CF patients. MexZ is shown to be the most frequently mutated gene in P. aeruginosa isolated from CF patient lungs, confirming its importance in multidrug resistance. Here we present the crystal structure of MexZ at 2.9Å. Combining the structural information with biochemical data on key mutants identified, we provide an explanation for the structural and functional consequences of these mutants. This work provides a framework for further characterisation of MexZ in order to fully understand its regulation and induction.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Diversity in structural consequences of MexZ mutations in Pseudomonas aeruginosa.Chem Biol Drug Des. 2013 May;81(5):600-6. doi: 10.1111/cbdd.12104. Chem Biol Drug Des. 2013. PMID: 23611117
-
MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA.FEMS Microbiol Lett. 2004 Sep 1;238(1):23-8. doi: 10.1016/j.femsle.2004.07.010. FEMS Microbiol Lett. 2004. PMID: 15336398
-
Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.Clin Microbiol Infect. 2004 Oct;10(10):877-83. doi: 10.1111/j.1469-0691.2004.00991.x. Clin Microbiol Infect. 2004. PMID: 15373880
-
Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.Biometals. 2009 Feb;22(1):53-60. doi: 10.1007/s10534-008-9197-9. Epub 2009 Jan 7. Biometals. 2009. PMID: 19130260 Review.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Cited by
-
MexXY multidrug efflux system of Pseudomonas aeruginosa.Front Microbiol. 2012 Nov 28;3:408. doi: 10.3389/fmicb.2012.00408. eCollection 2012. Front Microbiol. 2012. PMID: 23233851 Free PMC article.
-
Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts.Sci Rep. 2018 Aug 21;8(1):12512. doi: 10.1038/s41598-018-30972-y. Sci Rep. 2018. PMID: 30131514 Free PMC article.
-
Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis.Ann Clin Microbiol Antimicrob. 2014 Jan 6;13:2. doi: 10.1186/1476-0711-13-2. Ann Clin Microbiol Antimicrob. 2014. PMID: 24393536 Free PMC article.
-
Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.Microorganisms. 2022 Jun 16;10(6):1239. doi: 10.3390/microorganisms10061239. Microorganisms. 2022. PMID: 35744757 Free PMC article. Review.
-
Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Antimicrob Agents Chemother. 2014. PMID: 24145539 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources